Similarly, results were observed in GLUT1 expression, which was 2.7-fold lower in patients with severe COVID-19 (0.41 [0.09-2.62]) compared to controls (1.12 [0.39-2.45]), P = 0.049. The gene discussed is SLC2A1; the disease is COVID-19.